Eli Lilly Sues Denver Clinic Over Sale of Unapproved Diabetes and Obesity Drugs

Eli Lilly & Co. has initiated legal action against a health clinic in Denver, accusing it of selling “unapproved and potentially dangerous” drugs. These drugs are reportedly marketed for the treatment of type 2 diabetes and obesity. According to Eli Lilly, such actions could mislead consumers into believing that the pharmaceutical company’s approved medications by the U.S. Food and Drug Administration (FDA) are ineffective. This lawsuit highlights the ongoing challenges pharmaceutical companies face in ensuring the integrity and safety of medications available to consumers. For more details, please refer to the article on Law360.